India · Delayed Price · Currency is INR Clinitech Laboratory Statistics
Total Valuation
BOM:544220 has a market cap or net worth of INR 80.11 million. The enterprise value is 64.41 million.
| Market Cap | 80.11M |
| Enterprise Value | 64.41M |
Important Dates
The next estimated earnings date is Thursday, November 12, 2026.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOM:544220 has 2.28 million shares outstanding. The number of shares has increased by 9.65% in one year.
| Current Share Class | 2.28M |
| Shares Outstanding | 2.28M |
| Shares Change (YoY) | +9.65% |
| Shares Change (QoQ) | +88.82% |
| Owned by Insiders (%) | 71.08% |
| Owned by Institutions (%) | n/a |
| Float | 660,146 |
Valuation Ratios
The trailing PE ratio is 19.18.
| PE Ratio | 19.18 |
| Forward PE | n/a |
| PS Ratio | 0.84 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 15.41 |
| EV / Sales | 0.68 |
| EV / EBITDA | 6.34 |
| EV / EBIT | 12.68 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.50, with a Debt / Equity ratio of 0.06.
| Current Ratio | 6.50 |
| Quick Ratio | 3.50 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.53 |
| Debt / FCF | -0.33 |
| Interest Coverage | 15.63 |
Financial Efficiency
Return on equity (ROE) is 4.59% and return on invested capital (ROIC) is 4.60%.
| Return on Equity (ROE) | 4.59% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 4.60% |
| Return on Capital Employed (ROCE) | 5.06% |
| Weighted Average Cost of Capital (WACC) | 5.44% |
| Revenue Per Employee | 585,877 |
| Profits Per Employee | 25,796 |
| Employee Count | 162 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 4.18 |
Taxes
In the past 12 months, BOM:544220 has paid 1.81 million in taxes.
| Income Tax | 1.81M |
| Effective Tax Rate | 30.41% |
Stock Price Statistics
The stock price has decreased by -33.14% in the last 52 weeks. The beta is 0.23, so BOM:544220's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -33.14% |
| 50-Day Moving Average | 38.93 |
| 200-Day Moving Average | 46.57 |
| Relative Strength Index (RSI) | 40.20 |
| Average Volume (20 Days) | 2,040 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:544220 had revenue of INR 94.91 million and earned 4.18 million in profits. Earnings per share was 1.83.
| Revenue | 94.91M |
| Gross Profit | 68.61M |
| Operating Income | 5.08M |
| Pretax Income | 5.96M |
| Net Income | 4.18M |
| EBITDA | 10.16M |
| EBIT | 5.08M |
| Earnings Per Share (EPS) | 1.83 |
Balance Sheet
The company has 21.12 million in cash and 5.38 million in debt, with a net cash position of 15.75 million or 6.90 per share.
| Cash & Cash Equivalents | 21.12M |
| Total Debt | 5.38M |
| Net Cash | 15.75M |
| Net Cash Per Share | 6.90 |
| Equity (Book Value) | 92.53M |
| Book Value Per Share | 40.52 |
| Working Capital | 62.40M |
Cash Flow
In the last 12 months, operating cash flow was -7.93 million and capital expenditures -8.26 million, giving a free cash flow of -16.18 million.
| Operating Cash Flow | -7.93M |
| Capital Expenditures | -8.26M |
| Depreciation & Amortization | 5.08M |
| Net Borrowing | 5.38M |
| Free Cash Flow | -16.18M |
| FCF Per Share | -7.09 |
Margins
Gross margin is 72.29%, with operating and profit margins of 5.35% and 4.40%.
| Gross Margin | 72.29% |
| Operating Margin | 5.35% |
| Pretax Margin | 6.28% |
| Profit Margin | 4.40% |
| EBITDA Margin | 10.70% |
| EBIT Margin | 5.35% |
| FCF Margin | n/a |
Dividends & Yields
BOM:544220 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.65% |
| Shareholder Yield | -9.65% |
| Earnings Yield | 5.22% |
| FCF Yield | -20.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BOM:544220 has an Altman Z-Score of 4.86 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.86 |
| Piotroski F-Score | 3 |